EXPERT COMMENTARIES

The recent European Atherosclerosis Society Consensus Statement on triglyceride-rich lipoproteins (TRLs) and their remnants is the culmination of an 18-month wide-ranging review of the very complex relationship between elevated triglyceride levels and cardiovascular disease.1 Professor Gary Lewis, Director of the Banting and Best Diabetes Centre at the University of Toronto, Canada, and co-author of the report […]

Recent guidance on the management of persistent hypertriglyceridaemia from the American College of Cardiology (ACC) reflects evolving understanding of residual cardiovascular risk in patients whose triglyceride (TG) levels are raised despite the use of statins.¹
Dr Michael Miller, Professor of Cardiovascular Medicine at the University of Maryland, Baltimore, USA, and co-author of the publication explains […]